Mersana Therapeutics | ARS:年度報告
04/26 06:28 (美東)
Mersana Therapeutics | DEF 14A:股東委託書決議
04/26 06:09 (美東)
Mersana Therapeutics | DEFA14A:其他
04/26 06:08 (美東)
Mersana Therapeutics | 4:持股變動聲明-董事 Alleva Lawrence M
04/03 20:19 (美東)
Mersana Therapeutics | 8-K:重大事件
02/28 16:16 (美東)
Mersana Therapeutics | 424B5:募資說明書
02/28 16:15 (美東)
Mersana Therapeutics | POS AM:修改註冊聲明表
02/28 16:10 (美東)
Mersana Therapeutics | 10-K:年度報表
02/28 08:52 (美東)
Mersana Therapeutics | POSASR:註冊聲明修正稿
02/28 08:47 (美東)
Mersana Therapeutics | 8-K:Mersana Therapeutics提供最新業務並公佈2023年第四季度和全年財務業績
02/28 07:12 (美東)
Mersana Therapeutics | 4/A:持股變動聲明(修正)-高管 Mandelia Ashish
02/16 16:33 (美東)
Mersana Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Venrock Healthcare Capital Partners III, L.P.(9.4%),VHCP Co-Investment Holdings III, LLC(9.4%)等
02/14 20:58 (美東)
Mersana Therapeutics | SC 13G:超過5%持股股東披露文件-SilverArc Capital Management, LLC(5.3%),Devesh Gandhi(5.3%)
02/14 20:48 (美東)
Mersana Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-OrbiMed Capital LLC(0.0%),OrbiMed Advisors LLC(0.0%)
02/14 18:58 (美東)
Mersana Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Avoro Capital Advisors LLC(0%),Behzad Aghazadeh(0%)
02/14 09:22 (美東)
Mersana Therapeutics | SC 13G:超過5%持股股東披露文件-Balyasny Asset Management L.P.(8.04%),BAM GP LLC(8.04%)等
02/14 07:26 (美東)
Mersana Therapeutics | SC 13G:超過5%持股股東披露文件-The Vanguard Group(5.17%)
02/13 22:44 (美東)
Mersana Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-BlackRock, Inc.(6.5%)
01/29 15:31 (美東)
Mersana Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-STATE STREET CORPORATION(1.93%)
01/22 00:00 (美東)
Mersana Therapeutics | 4:持股變動聲明-董事 Protopapas Anna
01/17 00:00 (美東)
暫無數據
暫無數據